摘要
目的:探讨阿魏酸钠联合腹膜透析对终末期糖尿病肾病合并心力衰竭的临床研究。方法:选取在2016年6月~2017年9月于某院收治的80例终末期糖尿病肾病合并心力衰竭患者,并分为对照组与研究组,对照组仅采取腹膜透析治疗,研究组则采取阿魏酸钠联合腹膜透析进行治疗。结果:两组腹膜透析后舒张压显著优于治疗前,差异有统计学意义(P<0.05);研究组腹膜透析后舒张压、收缩压、血清内胆固醇与甘油三酯含量、脑钠肽水平均显著优于对照组,差异有统计学意义(P<0.05)。结论:对于终末期糖尿病肾病合并心力衰竭病人采用阿魏酸钠联合腹膜透析具有不错的临床治疗效果,值得推广。
Objective： To explore the clinical study of sodium ferulate combined peritoneal dialysis in pa with end stage diabetic nephropathy stage diabetic nephropathy complicated with Methods： 80 patients with end tal from June 2016 to September 2017 were selected and divided into control group and study group. The control group was treated with peri toneal dialysis only, while the study group was treated with sodium ferulate combined with peritoneal dialysis. Results： The diastolic blood pressure of two groups after peritoneal dialysis were significantly better than that before treatment, and the difference was statistically significant （P〈0.05）. Diastolic blood pressure, systolic blood pressure, serum cholesterol and triglyceride content and brain natriuretic peptide levels in the study group were significantly higher than those in the control group, with statistically significant differences （P〈0.05）. Conclusion： Sodium feruate combined with peritoneal dialysis is effective in treating patients with end stage diabetic nephropathy complicated with heart failure,is worthy of popularizing.
作者
秦测
蔡晓林
黄云青
Qin Ce(Department of Internal Medicine,Puning People＇s Hospital,Puning 515300)
出处
《数理医药学杂志》
2018年第12期1841-1842,共2页
Journal of Mathematical Medicine
关键词
阿魏酸钠
腹膜透析
终末期糖尿病肾病
心力衰竭
sodium ferulate
peritoneal dialysis
end stage diabetic nephropathy
heart failure
